BRKR
Get informed when a big investor buys or sells
+ FollowOvervalued by 81.3% based on the discounted cash flow analysis.
| Market cap | $9.07 Billion |
|---|---|
| Enterprise Value | $11.24 Billion |
| Dividend Yield | $0.20 (0.34%) |
| Earnings per Share | $-0.15 |
| Beta | 1.28 |
| Outstanding Shares | 152,200,000 |
| P/E Ratio | -85.21 |
|---|---|
| PEG | 10.87 |
| Price to Sales | 2.58 |
| Price to Book Ratio | 3.79 |
| Enterprise Value to Revenue | 3.21 |
| Enterprise Value to EBIT | 458.86 |
| Enterprise Value to Net Income | -158 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.98 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1234▼ 65.42% |
|---|---|
| Total Calls | 1,536,900▲ 609.23% |
| Total Puts | 189,600▲ 12.52% |
Holdings and activity of institutional investors.
| Ownership % | 99.19%▲ 9.00% |
|---|---|
| Total Invested | $8.72B▲ 76.35% |
| Investors Holding | 429▲ 77.00% |
No data
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...